Abdi Ibrahim Ilac San. ve Tic A.S.

Quick facts

Phase 3 pipeline

• AI201901 · Unknown
  AI201901 is a small molecule drug that targets the molecular target.

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• Abdi Ibrahim Ilac San. ve Tic A.S. portfolio CI brief
• Abdi Ibrahim Ilac San. ve Tic A.S. pipeline updates RSS